Article
GLS1 is a Protective Factor Rather than a Molecular Target in ARID1A-Mutated Ovarian Clear…
medRxiv · 2021 · Clemente, V.; Nelson, A.; Erickson, B.; Baker, R.; Rubin, N.; Khalifa, M.; Hoshino, A.; Shetty, M.; Lou, E.; Bazzaro, M.
Key facts
| Title | GLS1 is a Protective Factor Rather than a Molecular Target in ARID1A-Mutated Ovarian Clear Cell Carcinoma |
|---|---|
| First author | Clemente, V.; Nelson, A.; Erickson, B.; Baker, R.; Rubin, N.; Khalifa, M.; Hoshino, A.; Shetty, M.; Lou, E.; Bazzaro, M. |
| Journal | medRxiv |
| Published | Sep 4, 2021 |
| DOI | 10.1101/2021.09.03.457161 |
| Product codes mentioned | GIA, JCC, MVU, NJT, PPM |
At a glance
- None FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1